Navigation Links
Icagen Board Beginning to Follow Xmark Direction
Date:2/2/2009

RIDGEFIELD, Conn., Feb. 2 /PRNewswire/ -- Xmark Opportunity Partners, LLC ("Xmark"), the sole member of the investment manager of Xmark Opportunity Fund, L.P. and Xmark Opportunity Fund, Ltd., has, in the past, sent letters to the Board of Directors of Icagen, Inc. (Nasdaq: ICGN) setting forth its dissatisfaction with the company's corporate governance, management and strategic direction. Xmark would like to take this opportunity to respond to the Form 8-K filed by the company on January 29, 2009.

While Xmark applauds the Compensation Committee of the Board of Directors for choosing to not pay cash bonuses to the company's executive officers for 2008, it believes that this is but a small step in the right direction. Xmark is pleased that cash bonuses for the company's executive officers for 2009 will be based, in part, on "building shareholder confidence." However, Xmark believes that there are additional steps that can be taken by the company to pare its cash-burn requirements. As Xmark has repeatedly pointed out to the company, these are challenging economic times; the Board of Directors should continue to tighten the company's economic belt for the coming years.

Xmark remains committed to monitoring its significant common stock investment in the company and remains hopeful that it can engage in productive dialogue with the company to help it maximize shareholder value by, among other things, pursuing strategic alternatives.


'/>"/>
SOURCE Xmark Opportunity Partners, LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Xmark Sends Letters to Icagens Board of Directors: Questions Companys Leadership as Well as Motives Behind Adoption of Poison Pill
2. Pharmacy Technician Certification Board (PTCB) Unveils New Testing Features for 2009: PTCB Exam to be Offered Daily; Test Results Given to Candidates Immediately in 2009
3. MedCom USA, Inc. Announces Appointment of One New Board Member and Removal of Two Existing Board Members
4. Elite Meetings International Names New Advisory Board
5. Light Sciences Oncology Elects Former FDA Commissioner Frank Young, M.D., Ph.D., to Board of Directors
6. Shaklee Partners With U.S. Ski Team and U.S. Snowboarding in Preparation for the 2010 Games in Vancouver
7. The Advisory Board Company Schedules Third Quarter Investor Conference Call for February 9, 2009
8. Bruce E. Mosler, President and CEO of Cushman & Wakefield Elected to CASA* Board
9. Quest Diagnostics Board Authorizes $500 Million in Share Repurchases
10. Dr Nabil Dib Takes on Special Advisor Role to the Stemedica Board of Directors
11. PPGI Appoints Rick Strandlund to the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Thank you ... Diego on February 8-10. , This event was exclusive to providers and offered ... , The meeting took place at the Manchester Grand Hyatt where attendees gathered for ...
(Date:3/28/2017)... , ... March 28, 2017 , ... Bacteria and fungi are probably not the first ... bad. In fact, including the right microorganisms in your diet can actually improve health outcomes. ... , This is the topic of a new peer-reviewed paper led by ...
(Date:3/27/2017)... ... March 27, 2017 , ... Drs. ... smile makeovers without requiring a referral. Trimble Dental offers a variety of ... dentistry and dental implants. Whether patients have discolored, crooked or missing teeth in ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... site attention and engagement over the household brands of Top-20 pharma by optimizing ... discuss how partnering with the right outsourcing payments provider can provide the technology, ...
(Date:3/27/2017)... Reston, VA (PRWEB) , ... March 27, 2017 ... ... mobile application containerization, today announced it will co-exhibit with technology partners LG Business ... held at the Marriott Metro Center in Washington D.C., will provide education and ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  ImMAGE Biotherapeutics (OTCMKTS: ... immunotherapy successfully passed early toxicology and efficacy studies. The ... to target a specific protein, MAGE A, in an ... breast cancer. After 4 weeks of ... to show very little toxicity in a full toxicology ...
(Date:3/27/2017)... 27, 2017  Sanderling Ventures, portfolio company, Torax ... division of Johnson & Johnson. Torax manufactures and markets ... of gastro-esophageal reflux disease (GERD). The LINK device ... and the procedure is currently available in the ... Medical was founded by Sanderling Ventures, Mayo Medical ...
(Date:3/27/2017)... AVIV, Israel , March 27, 2017 ... on oncology and immunology, announced today that AGI-134, an immunotherapy ... announced acquisition of Agalimmune Ltd., will be featured at the ... in Washington, DC to be ... ...
Breaking Medicine Technology: